Bioluminescent imaging of Trypanosoma cruzi infection in Rhodnius prolixus
© Henriques et al.; licensee BioMed Central Ltd. 2012
Received: 16 May 2012
Accepted: 19 September 2012
Published: 26 September 2012
Usually the analysis of the various developmental stages of Trypanosoma cruzi in the experimentally infected vertebrate and invertebrate hosts is based on the morphological observations of tissue fragments from animals and insects. The development of techniques that allow the imaging of animals infected with parasites expressing luciferase open up possibilities to follow the fate of bioluminescent parasites in infected vectors.
D-luciferin (60 μg) was injected into the hemocoel of the whole insect before bioluminescence acquisition. In dissected insects, the whole gut was incubated with D-luciferin in PBS (300 μg/ml) for ex vivo bioluminescence acquisition in the IVIS® Imaging System, Xenogen.
Herein, we describe the results obtained with the luciferase gene integrated into the genome of the Dm28c clone of T. cruzi, and the use of these parasites to follow, in real time, the infection of the insect vector Rhodnius prolixus, by a non- invasive method. The insects were evaluated by in vivo bioluminescent imaging on the feeding day, and on the 7 th, 14 th, 21 st and 28 th days after feeding. To corroborate the bioluminescent imaging made in vivo, and investigate the digestive tract region, the insects were dissected. The bioluminescence emitted was proportional to the number of protozoans in regions of the gut. The same digestive tracts were also macerated to count the parasites in distinct morphological stages with an optical microscope, and for bioluminescence acquisition in a microplate using the IVIS® Imaging System. A positive correlation of parasite numbers and bioluminescence in the microplate was obtained.
This is the first report of bioluminescent imaging in Rhodnius prolixus infected with trypomastigotes of the Dm28c-luc stable strain, expressing firefly luciferase. In spite of the distribution limitations of the substrate (D-luciferin) in the insect body, longitudinal evaluation of infected insects by bioluminescent imaging is a valuable tool. Bioluminescent imaging of the digestive tract infected with Dm28c-luc is highly sensitive and accurate method to track the fate of the parasite in the vector, in the crop, intestine and rectum. This methodology is useful to gain a better understanding of the parasite – insect vector interactions.
KeywordsTrypanosoma cruzi Rhodnius prolixus Chagas diseases Bioluminescent imaging Bioluminescence Luciferase
Chagas disease is an endemic parasitic disease that is ranked as one of the most important in several areas of Latin America. Triatomine bugs are vectors of the parasite Trypanosoma cruzi, the causative agent of Chagas disease. The gut of the vector Rhodnius prolixus is basically comprised of three major regions, the foregut (stomach or crop), the midgut (intestine), and the hindgut (rectum); however more elaborate divisions have been proposed [1, 2]. These different regions are important for the development of the parasite [3, 4]. The vector host digestion starts when the insect ingests blood from the vertebrate host that is then stored in the crop where it is concentrated and hemolyzed. Subsequently, it passes into the intestine for digestion and absorption, followed by storage of the non absorbed products in the rectum and subsequent release. The remaining compounds are swept by the urine and feces that are secreted rapidly after new blood ingestion [2, 5].
T. cruzi development begins inside the insect vector as soon as the insect has fed on the blood of an infected host. In the crop, most of the trypomastigotes differentiate into epimastigotes, the main replicative stage. A significant proportion of parasites are lysed in part due to the interaction with bacteria found in the crop microbiota . Subsequently the remaining epimastigotes migrate to the intestine where they proliferate and adhere to the perimicrovillar membranes. Then the epimastigotes transform into the non-replicative, but infective metacyclic trypomastigotes, which are released in the urine and feces [2, 5, 7, 8].
Until now the study of the distribution of T. cruzi inside the insect vector has been based on the microscopic examination of the digestive tract following dissection of the insects. However, recently the use of bioluminescent imaging of the whole animal has shown that it is possible to follow the parasite in vivo within their mammalian hosts if the parasites are labeled with luciferase [9, 10]. In the present work we describe the results obtained with the integration of the luciferase gene in the genome of the Dm28c clone of T. cruzi, and the use of the labeled parasites to follow, in real time, the infection of the invertebrate vector R. prolixus. We observed the infected insects for one month after feeding/infection, and the light emitted could be traced continuously within the insect. We also analyzed insects that were dissected to expose the digestive tract. This methodology will be useful for further studies to acquire a better understanding of the parasite – insect vector interactions.
Expression of firefly luciferase (Fluc) in Trypanosoma cruzi
The luciferase gene was amplified by PCR using specific primers. The forward primer contains an XbaI site and the Kozak sequence (underlined), upstream of the start codon, 5′- GCTCTAGA GCCACC ATGGAAGACGCCAAAAACATAAAG – 3′ (F-luc), and the reverse primer contains an XhoI site (underlined) 5′- CCGCTCGAG CGGTTACACGGCGATCTTTCC- 3′ (R-luc). Amplification was carried out using the Tli DNA Polymerase (Promega) and the following PCR conditions: 94oC, 5 min; 94oC, 30 sec; 60oC, 30 sec; 72oC, 2 min, 30 cycles; 72oC, 10 min. The PCR product was cloned into the Zero Blunt TOPO PCR Cloning Kit (Invitrogen), digested from the TOPO vector and subcloned into the integrative pTREX vector at the XbaI and XhoI restriction sites . The construction was sequenced on an ABI 3730 Genetic Analyzer (Applied Biosystems), using the sequencing platform form PDTIS/FIOCRUZ.
T. cruzi epimastigotes of Dm28c clone were suspended at 1 x 108 cells/mL in electroporation buffer (EPB) containing 137 mM NaCl; 5 mM KCl; 0.7 mM Na2HPO4; 6 mM glucose; 21 mM HEPES, pH 7.3. The cellular suspension (400 μl) was mixed with 50 μg of plasmid, digested with NheI, placed in a 0.2 cm cuvette and subjected to a pulse of 0.45 kV, 500 μF at room temperature in a Gene Pulser apparatus (BioRad Laboratories) . The parasites were re-suspended in LIT medium and stable transformants were selected with 200 to 500 μg/mL of G418. Thereafter, the high expressing epimastigotes were selected by serial dilution in a 96 well plate, and selected by bioluminescent emission with Steady-Glo reagent (Promega) in a microplate reader SpectraMax2.
Genomic southern blot
To examine the integration of the Fluc gene and the pTREX construction in the T. cruzi genome we performed Southern blot of the epimastigote genomic DNA. Epimastigotes (108) were lysed with 1 ml of buffer (10 mM Tris–HCl, pH7.5, 100 mM NaCl, 0.5% SDS 25 mM EDTA and 0.1 mg/ml of proteinase K). The DNA was isolated by phenol:chloroform extraction and recovered by ethanol precipitation. Genomic DNA from the wild type Dm28c and from the genetically modified Dm28c-luc strain were digested with Eco RI restriction enzyme, using the standard protocol, then the restriction fragments were separated by electrophoresis in agarose gel and transferred to a positively charged nylon membrane with a high salt buffer.
To produce the probe, pTREX-luc plasmid was digested with NheI and XhoI. A fragment of 2.2 kb, containing the neo gene and the gapdh intergenic region, was agarose gel purified and 1 μg was used as template to produce the probe with ready-to-go DNA labeling beads (GE Healthcare). Unlabeled dCTP was added to the reaction mixture according to the manufacturer’s protocol, and incubated for 24 hours. The length of the probe ranged from 200 to 1000 bp; unincorporated nucleotides and reaction buffer were removed by the Wizard® SV Gel and PCR Clean-Up System (Promega). The probe was labeled with alkaline phosphatase by the Gene Images AlkPhos Direct Labeling and Detection System (GE Healthcare) and 50 ng of labeled probe was added to 30 ml of hybridization buffer in a bottle containing the nylon membrane with immobilized DNA, and was then incubated in a hybridization oven for 48 hours at 55oC. After hybridization the blots were washed following the manufacturer recommendations. The washed blots were placed directly into the detection system protocol, using the CDP-Star chemiluminescent detection reagent, which uses the probe-bound alkaline phosphatase to catalyze the decomposition of a stabilized dioxetane substrate (GE Healthcare). Autoradiography films were exposed from 10 minutes to 2 hours.
PCR and sequencing to identify the pTREX-luc integration
To identify the integration of the pTREX-luc construction in the genome, a couple of primers were designed to align the transcription start point, tsp1, of the ribosomal promoter from pTREX, F-TSP1- 5′TCATGGAGCGGTATTCTC-3′ and R-TSP1 5′GAGAATACCGCTCCATGA-3, and another pair of primers to align the ribosomal locus recombination site , F-RS pTREX- 5′-GTCCGAACGCGGAAATGT-3′ and R-RS pTREX- 5′-ACATTTCCGCGTTCGGAC-3′. PCR amplifications were performed using genomic DNA from Dm28c-luc as a template and a set of primers: 1- F-TSP1/R-LUC; 2- F-RS pTREX/R-LUC and; F-LUC/R-LUC using the following settings: 94oC, 2 min; 94oC, 30 sec; 60oC, 30 sec; 68oC, 2 min, 30 cycles; 72oC, 10 min and the Platinum Taq DNA Polymerase High Fidelity (Invitrogen). The PCR fragments were resolved by 1% agarose gel in Tris-Acetate- EDTA (TAE) buffer, stained with ethidium bromide and gel purified by the Wizard® SV Gel and PCR Clean-Up System (Promega). The PCR products were sequenced with primers specific for the ribosomal promoter region: F-TSP1; R-TSP1; F-RS pTREX; R-RS pTREX, on an ABI 3730 Genetic Analyzer (Applied Biosystems), using the sequencing platform from PDTIS/FIOCRUZ.
Genetically modified epimastigotes of T. cruzi (Dm28c-luc), expressing luciferase, and wild type (Dm28c clone) were cultivated in liver infusion tryptose (LIT) medium with 10% fetal calf serum, at 28oC until the logarithmic stage of growth . Epimastigotes of Dm28c-luc were cultivated in the same medium, but supplemented with G418 200 μg/ml. The non-infective and replicative epimastigotes were transformed into non-dividing and infective metacyclic trypomastigotes. This is a process known as metacyclogenesis, which is carried out by subjecting T. cruzi epimastigotes from the late exponential growth phase at a cell density of 3 x 107 cells/ml to nutritional stress in a triatomine artificial urine (TAU) medium (190 mM NaCl; 8 mM phosphate buffer, pH 6.0; 17 mM KCl; 2 mM MgCl2; 2mM CaCl2) for 2 hours. Then, a further incubation in TAU supplemented with amino acids and glucose (TAU3AAG) (TAU supplemented with 0.035% sodium bicarbonate, 10 mM L-proline, 50 mM sodium glutamate, 2 mM sodium L-aspartate, and 10 mM glucose) . Metacyclic parasites were used to infect the host cell LLCMK2, and trypomastigotes from the cell culture were used to infect the insects.
Fifth-instar Rhodnius prolixus larvae obtained from our colony were used throughout these studies. After molting, insects that had been starved for 15-20 days and weighed 35.2 ± 3.4 mg, were randomly chosen and then allowed to feed on defibrinated rabbit blood through a membrane feeding apparatus . Defibrinated rabbit blood used for feeding the insects was provided by the Laboratory Animals Creation Center of Fiocruz (Cecal). All research programs using Cecal respect the guidelines of the Ethics Committee on Animal Use (Ceua) composed of Fiocruz researchers and external consultants. A control group was fed with blood alone and infected groups on blood containing ~1 x 107 tissue culture-derived trypomastigotes of T. cruzi Dm28c clone per ml of blood meal. The experimental group was fed with blood infected with genetically modified trypomastigotes, Dm28 luc expressing luciferase, at 1.7 x 107 trypomastigotes per ml of blood. Only fully gorged insects were used (180.5 ± 22.1 mg) and partially fed insects were discarded. All insects were raised and maintained as previously described . To analyze the insect infection on the feeding day, D-luciferin substrate was given at 1 mg/mL by oral treatment together with the bloodmeal containing the wild type Dm28c or the genetically modified Dm28c-luc trypomastigotes and imaged in the IVIS® Lumina Imaging System at the Bioimaging Central Unit/National Institute of Science and the National Institute of Science and Technology for Structural Biology and Bioimaging INBEB/CENABIOII/UFRJ.
For bioluminescent imaging on days 7, 14, 21 and 28 after feeding, the insects were inoculated laterally in the thorax with 2 μl of D-luciferin solution (30 mg/ml) using a 30 gauge hypodermic needle (BD Precision Glide) adapted to a 10-μl Hamilton syringe. Afterwards, the insects were immobilized by attaching the dorsal region with a double-sided adhesive tape and after 5 min they were put into the IVIS® Lumina Xenogen equipment to acquire bioluminescence. To avoid mortality through successive inoculations we tested the acquisition of bioluminescent imaging with D-luciferin topical applications. The insects were immobilized as described above and 5 μl of D-luciferin solution (30 mg/ml) was applied over the insect ventral region. The insects were kept immobilized for 15 min to let the compound penetrate through the cuticle before capturing the bioluminescence. To analyze the parasite migration into the digestive tract, the insects were dissected and the organ was incubated with D-luciferin, 300 μg/mL in PBS, for 5 min in Petri dishes. The digestive tracts were then analyzed with the bioluminescence equipment, IVIS® Lumina Xenogen, at the Bioimaging Central Unit of the National Institute of Science and the National Institute of Science and Technology for Structural Biology and Bioimaging INBEB/CENABIOII/UFRJ .
In vivo and ex vivo bioluminescent imaging
In vivo bioluminescent imaging was done with fifth-instar R. prolixus larvae infected with T. cruzi, that after treatment with D-luciferin were evaluated on the feeding day and on days 7, 14, 21 and 28 after feeding in the bioluminescence image system (IVIS 100; Xenogen, Alameda, CA). The IVIS® Lumina, Xenogen is composed of a highly sensitive CCD camera, a light-tight imaging chamber with complete computer automation, and the Living Image® software for image acquisition and analysis. To acquire the bioluminescent images of the low level of luminescence emissions in the insects and their digestive tracts, parameters such as the time of exposure, which varied from some seconds until 5 minutes, the size of pixel represented by the binning medium and the field of view (FOV) in the B position, 7.5 cm, with automatic focus were used. The Living Image software automatically co-registers the luminescent image, taken in darkness and displayed in pseudo-colors that represent the intensity of the signal, and the photographic image to generate an overlay image.
To confirm the bioluminescent imaging made in vivo and to evaluate the digestive tract of the infected insect on different days of the development cycle, the insects were dissected and the whole gut removed. The digestive tract, ex vivo, was incubated with D-luciferin and the luminescence acquired for a few seconds to 5 minutes in the IVIS® Lumina from Xenogen. To correlate the luminescent emissions and the number of parasites, the whole digestive tract was homogenized in 1ml of sterile phosphate saline buffer (PBS) and the parasites counted in a Neubauer chamber. Afterwards, macerated digestive tracts were centrifuged at 2200 g for 10 min, the pellet was re-suspended in 200 μl of PBS containing D-luciferin 300 μg/ml and then placed into the 24 wells microplate, which was imaged for bioluminescence in the IVIS® Lumina Xenogen, at the Bioimaging Central Unit of the National Institute of Science and the National Institute of Science and Technology for Structural Biology and Bioimaging INBEB/CENABIOII/UFRJ.
Two experiments were done with 129 and 46 insects. To measure the photon radiance, regions of interest (ROI) were selected on the surface of the insect with the automatic ROI tool and the bioluminescence was measured quantitatively by the Living Image® software, which gave the total flux of photons or radiance (photons/second from the surface) in each pixel summed or integrated over the ROI area, in a square centimeter (cm2) of the tissue, multiplied by one steradian (sr). The photon radiance is displayed as the average radiance, which is the sum of the radiance from each pixel inside the ROI/number of pixels or super pixels (photons/sec/cm2/sr) and the standard deviation of the pixel radiance inside the ROI. The correlation coefficient was calculated by linear regression of the average radiance versus the number of parasites counted in the Neubauer chamber. The results are presented as the average and standard error of photon radiance.
Results and discussion
Expression of luciferase in Trypanosoma cruzi
Bioluminescent emission from 24 well plate
Avg Radiance (p/s/cm2/sr)
1.8 x 1010
5.2 x 109
9.3 x 108
2.4 x 108
2.6 x 108
1.1 x 108
1.8 x 107
9.8 x 106
To evaluate the integration of pTEX-luc, PCR of genomic DNA was performed using specific primers to amplify regions of the ribosomal promoter, followed by the luciferase gene. Single PCR products were amplified from genomic DNA of cloned Dm28c-luc, generating fragments of expected size as compared with PCR amplified fragments of pTREX-luc plasmid (Figure 2 B). The PCR of wild type Dm28c genomic DNA was negative for the pairs of primers tested (Figure 2 B). Fragments of 2.4 kb and 2.7 kb were amplified by PCR with two sets of primers specific for the ribosomal promoter sequences coupled to the luciferase gene, and a PCR product of 1.6 kb was amplified with primers specific for the luciferase gene (Figure 2 B). The PCR products of 2.4 kb and 2.7 kb, purified from agarose gel, were sequenced and the site of recombination (RS) in the ribosomal promoter, proposed previously as the integration locus in the genome , displayed 87 % identity to the ribosomal promoter sequence in the pTREX-luc plasmid, as indicated (Figure 2 C).
Genetically modified Dm28c-luc versus wild type Dm28c strain
A comparison between the Rhodnius prolixus vector infected with T. cruzi Dm28c wild type and Dm28c-luc genetically modified was carried out to evaluate the capacity of the genetically modified strain to infect and maintain the infection. Thus, both groups of infected insects were subjected to the same procedure of feeding. Insects infected with Dm28c wild type ingested also D-luciferin, as a negative control of bioluminescent imaging (not shown) and as a control of infection. They displayed similar mortality rates of 24% and 26%, respectively. The percentage of insects infected with Dm28c-luc was 51%, 21 days (n = 35) after feeding, as evaluated by bioluminescent emission, and ranged from 50% to 47%, 21 days (n = 10) and 28 days (n = 19) post infection, as evaluated by parasite counting in dissected digestive tracts. Insects infected with Dm28c wild type displayed 40% infection, as evaluated after dissection and parasite counting 14 days (n = 10) and 21 days (n = 5) after feeding.
In both groups, we observed epimastigotes, spheromastigotes and metacyclic trypomastigotes in the macerated tissues of the digestive tract, which displayed a median of 2.5 x 104 parasites (from 103 to 3.6 x 105 parasites per insect, n = 7) for Dm28c-luc and a median of 3 x 104 parasites (from 2 x 103 to 3.7 x 105 parasites per insect, n = 4) for the Dm28c wild type infected insects, that was maintained for twenty one days of follow up. These values show that Dm28c wild type strain and Dm28c-luc genetically modified have similar infection and proliferative rates in the gut of Rhodnius prolixus.
Insect immobilization and evaluation of substrate delivery method
Two methods of D-luciferin delivery were tested: injection into the hemocoel/hemolymph and topical application. Substrate injection in the hemolymph is used as a routine for applying drugs and compounds. D-luciferin injetion is fast and the insects can be evaluated by bioluminescent imaging after 5 minutes (Figure 3 B), however, it increases the chance that the insects die with successive cuticle damage. Nevertheless the D-luciferin topical application is an excellent tool to administer the compound to the insect without cuticle damage, especially if it is important to keep the insect alive for several days to acquire more bioluminescence data. This delivery method requires more substrate and prolonged incubation (15 minutes) to allow D-luciferin to penetrate the cuticle and then reach the digestive tract (Figure 3 C). In spite of this, both methods of D-luciferin delivery show limitations related to the distribution of D-luciferin throughout the insect body, but the topical application can be more prone to produce false negatives (Figure 3 D). Thus, the injection of D-luciferin into the hemolymph was the method of choice to perform the bioluminescence evaluation and radiance quantification in this work.
Firefly luciferase (luc), one of the most common bioluminescent proteins employed for in vivo studies, requires the injection of the substrate D-luciferin to produce bioluminescent signals. D-luciferin can only produce light upon oxidation and the route of substrate injection can have influential effects on the emission of the bioluminescent signal. Small mammal models have shown that, depending on the method of injection, intraperitoneal, subcutaneous or intravenous injection, the absorption rate of the substrate and distribution throughout the tissues can lead to variations in the bioluminescent signal and affect reproducibility . Studies using radio-labeled D-luciferin injected intravenously demonstrated that the uptake rate of the substrate is actually slower in gastrointestinal organs, pancreas, and spleen than would be achieved using intraperitoneal injection . However, the intravenous injection of the substrate generates a faster bioluminescent signal but with a shorter duration than the intraperitoneal route [18, 19]. Thus, the injection method should be considered in light of the proposed objectives of any study.
Bioluminescent imaging after feeding
A bioluminescent image of Rhodnius prolixus infected with T. cruzi expressing luciferase acquired in an IVIS® Imaging System is a diffuse projection on the surface of the insect from the trypanosome inside the digestive tract. The bioluminescent spots on the insect are associated with foci of infection along the digestive tract, and the diffusion of D-luciferin.
Bioluminescent emission in the insect and dissected digestive tracts of Rhodnius prolixus infected with Dm28c-luc
Bioluminescence Days after feeding
Insect Radiance (p/s/cm2/sr)
Dissected Digestive Tract Radiance (p/s/cm2/sr)
2.1x 10 11
9.1 x 1010
4.8 x 1011
1.8 x 10 8
6.9 x 105
4.9 x 109
1.6 x 10 9
1.3 x 108
3.3 x 109
8.8 x 10 7
4.2 x 106
7.9 x 109
9.0 x 10 8
1.8 x 107
6.9 x 109
3.9 x 10 7
3.8 x 106
2.8 x 109
4.0 x 10 8
6.3 x 107
2.9 x 109
6.9 x 10 7
1.4 x 107
2.7 x 108
1.3 x 10 9
1.8 x 107
4.8 x 109
In experiments using several insects, it is worth noting that insects with high photon emission can mask the spots of insects with low photos emission, obtained by the CCD camera. Bioluminescent imaging in Living Image software has a minimum threshold, the image is an overlay of a luminescent image over a grayscale photographic image, the upper (Max Bar) and lower limits (Min Bar) are in the color table display. All photon emissions below the Min Bar setting of relatively lower bioluminescent emission are not displayed in the pseudocolor image, and are transparent, to avoid saturation of the image.
Insect classification by bioluminescent emission
Bioluminescence 7 days after feeding
Insect Radiance (p/s/cm2/sr)
Super High (n = 8)
2.5 x 109
1 x 109
4.9 x 109
High (n = 30)
3.2 x 108
1 x 108
8.8 x 108
Medium (n = 18)
3.6 x 107
1.4 x 107
9.8 x 107
Low (n = 8)
5.1 x 106
6.9 x 105
9.1 x 106
In our study the IVIS® Imaging System was set to acquire photons for 30 seconds to 5 minutes exposure, in the ex-vivo assay, and for 5 minutes, in the whole insect. To acquire all the information from the photons emitted by the whole insect and their tissues infected with T. cruzi Dm28c-luc, other parameters such as binning were considered. Therefore, after imaging a group of insects with high luminescence it is important to set up the equipment again to obtain images of insects with lower bioluminescence. If the luminescence does not appear it is recommended to increase the exposure time to 5 min before considering the insect negative. In addition, it is also recommendable to dissect the insect and make an ex vivo bioluminescent imaging.
Bioluminescent imaging 7 days after feeding: in vivo versus ex vivo evaluation
In the group of positive insects, bioluminescent emission could be classified in four degrees of photon radiance quantified in the bioluminescent spots on the insect surface (Table 3). More than 70% of luminescent insects displayed bioluminescence in the range of high photon radiance (30 insects) and medium photon radiance (18 insects), whose medians were 3.2 x 108 and 3.6 x 107, photons/sec/cm2/sr (Table 3) respectively. Some insects were selected from these groups and dissected. The crop, full of digested blood residues mixed with luminescent parasites, is susceptible to disruption during dissection, however, their digestive tracts displayed radiance consistently higher than the whole insect, median of 1.6 x 109 photons/sec/cm2/sr (Table 2). We also dissected three negative bioluminescent insects and observed that two were infected and just one was not. Therefore, from the 45 % negative bioluminescent insects a percentage is probably infected but due to D-luciferin diffusion and distribution throughout the insect body, the infection rate evaluated by bioluminescent imaging could be under detected.
Bioluminescent imaging 14 days after feeding, in vivo versus ex vivo evaluation
Photon emissions acquired by the CCD camera did not have enough spatial resolution to show the regions of the intestine and the coiled digestive tract inside the insect. In the insect the bioluminescent image is just a spot that represents part of the infection site. However, the dissected guts can show the precise localization of the parasites along the tract (Figures 5 A and B). In the intestine, scattering and diffusion of light throughout the tissues is not a limiting factor for bioluminescent imaging acquisition. Thus, in dissected insects fast and reliable information can be obtained from infected digestive tract using the CCD camera.
However, it is not always possible to show correlation between the number of parasites in dissected digestive tracts and the bioluminescence analyses in radiance photons/sec/cm2/sr. This could be related to the photons emitted from the source inside and along the tract, which will be compact or disperse depending on the amount of pathogens and their distribution throughout the gut (Figure 5 B). Another explanation could be the diversity of parasite life forms encountered inside the gut. Trypomastigote forms obtained from host cells, displayed lower bioluminescence than epimastigote forms (Figure 1 C) which suggest that metacyclic trypanosome is also a lower photon emitter compared to other forms found inside the gut.
Bioluminescent imaging 21 to 28 days after feeding, in vivo versus ex vivo evaluation
On the 21st and 28th days after feeding, ten and nineteen insects infected with Dm28c-luc were dissected. Metacyclic trypomastigotes, spheromastigotes and epimastigotes were found in the macerated tissues of the digestive tract. In the third week after feeding, the infection rate was maintained, 50% of insects were infected and the median was 4.1 x 104 parasites (from 1.5 x 104 to 105 parasites per insect, n = 5). After 4 weeks, nineteen insects were evaluated, 47 % of the insects remained infected, the parasites counted in the Neubauer chamber had a median of 105 parasites (from 2 x 104 to 2.7 x 105 parasites per insect, n = 9).
On the 21st and 28th days after feeding, a positive correlation between insect bioluminescent imaging and bioluminescence from dissected gut was expected, considering that the infection was more restricted to the terminal regions of the gut. However, due to the distribution of the substrate D-luciferin throughout the insect body, distribution of parasites inside the gut and the conformation of the intestine inside the hemocoel, the coefficient of correlation was low and some insects were false negatives. We observed occasionally that when the insect is colonized with a number of T. cruzi below or equivalent to 2.5 x 104 parasites, the insect can be negative but the dissected digestive tract displays the bioluminescence (Figure 7 D). After dissection bioluminescence could be quantified precisely in false negative insects, the median was 2.5 x 103 parasites (from 103 to 2.5 x 104 parasites per insect, n = 5) (Figure 7 D). Thus it is recommended to work with highly infected insects that can be followed up for a month, overcoming the limitations encountered with low parasite load, in infected insects.
Longitudinal evaluation of labeled insects
Previous studies, reported the use of parasites expressing fluorescent proteins to track the fate of the parasite inside the vector. Rhodnius prolixus infected with DsRed-labeled T.cruzi was used as a marker to follow the parasite life cycle and investigate co-infection with T. rangeli expressing GFP . Plasmodium falciparum genetically modified lines that stably express gametocyte-specific GFP-luciferase reporters were used as a tool to evaluate the dose- and time-dependent drug action on gametocyte maturation and transmission, evaluated by bioluminescent emission in a plate reader and by light fluorescence microscopy. Mature gametocytes treated with drugs, were formulated as artificial mosquito blood meals and fed to A. stephensi mosquitoes. Mosquito midguts were dissected 6 or 7 days after gametocyte ingestion to ascertain the percentage of infected mosquitoes and quantify oocyst production. However, the positive effect of drugs on the inhibition of mature gametocyte transmission to Anopheles mosquitoes was not evaluated by in vivo or ex vivo bioluminescent imaging but by oocyst quantification under a phase-contrast microscope .
The fact that dissected digestive tracts display higher bioluminescent emission than the intact insect is probably related to the diffusion of D-luciferin throughout the hemolymph and tissue regions. We can speculate that the substrate D-luciferin (a) is not achieving an adequate concentration in the anterior region of the insect, crop, (b) may be degraded in lipidic bodies, or (c) excreted through Malpighian tubules, involved in elimination of products of digestion, and in ionic and osmotic regulation through the action of channels, exchangers and transporters [22, 23]. D-luciferin is transported through the ABCG2/BRCP transporter , thus specific transporters and exchangers in the insect organs could increase the turnover of D-luciferin in the hemolymph, and reduce bioluminescent emission in the insect.
To our knowledge this is the first report of bioluminescent imaging in Rhodnius prolixus infected with Dm28c-luc trypomastigotes, expressing firefly luciferase. The strain displayed stable expression, and reproducible data could be acquired, as evaluated by bioluminescent imaging of intact as well as of dissected digestive tracts of Rhodnius prolixus, and confirmed by light microscopy observation of the parasites, in the macerated intestines. We can conclude that, bioluminescent imaging analysis offers a considerable quantity of information regarding the parasites movements in the digestive tract as evaluated by dissected guts.
The authors thank the Program for Technological Development in Tools for Health-PDTIS/FIOCRUZ and the National Institute of Science and the National Institute of Science and Technology for Structural Biology and Bioimaging- INBEB/CENABIOII/UFRJ, for use of its facilities. Cristina Henriques has a postdoctoral fellowship- PNPD 150209/2009-6/project 558945/2008-2 from CNPq. This project was supported by CNPq and FAPERJ -APQ1 E-26/171.172.2006.
- Billingsley PF, Downe AE: The effects of artificial diets on the anterior intestinal cell ultrastructure of Rhodnius prolixus (Hemiptera:Reduviidae). Int J Parasitol. 1989, 19 (3): 291-299. 10.1016/0020-7519(89)90140-9.View ArticlePubMedGoogle Scholar
- Kollien AH, Schaub GA: The development of Trypanosoma cruzi in Triatominae. Parasitol Today. 2000, 16: 381-387. 10.1016/S0169-4758(00)01724-5.View ArticlePubMedGoogle Scholar
- Garcia ES, Azambuja P: Development and interaction of Trypanosoma cruzi within the insect vector. Parasitol Today. 1991, 7: 240-244. 10.1016/0169-4758(91)90237-I.View ArticlePubMedGoogle Scholar
- Garcia ES, Azambuja P:Infection of triatomines with Trypanosoma cruzi.Molecular Biology of Insect Disease Vectors: A Methods Manual. Edited by: Crampton JM, Beard CB, Louis C. 1997, London, UK: Chapton and Hall, 146-155.View ArticleGoogle Scholar
- Garcia ES, Ratcliffe NA, Whitten MM, Gonzalez MS, Azambuja P: Exploring the role of insect host factors in the dynamics of Trypanosoma cruzi – Rhodnius prolixus interactions. J Insect Physiol. 2007, 53: 11-21. 10.1016/j.jinsphys.2006.10.006.View ArticlePubMedGoogle Scholar
- Azambuja P, Ratcliffe NA, Garcia ES: Towards an understanding of the interaction of Trypanosoma cruzi and Trypanosoma rangeli within the reduviid insect host, Rhodnius prolixus. An Acad Brasil Cienc. 2005, 77: 397-404.PubMedGoogle Scholar
- Garcia ES, Genta FA, Azambuja P, Schaub GA: Interactions between intestinal compounds of triatomines andTrypanosoma cruzi. Trends Parasitol. 2010, 26: 499-505. 10.1016/j.pt.2010.07.003.View ArticlePubMedGoogle Scholar
- Schaub GA: Interactions if trypanosomatids and triatomines. In Adv Insect Physiol. 2009, 37: 177-242.View ArticleGoogle Scholar
- Canavaci AMC, Bustamante JM, Padilla AM, Perez Brandan CM, Simpson LJ, Xu D, Boehlke CL, Tarleton RL: In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds. PLoS Neglected Trop Dis. 2010, 4: e740-10.1371/journal.pntd.0000740.View ArticleGoogle Scholar
- Hyland KV, Asfaw SH, Olson CL, Daniels MD, Engman DM: Bioluminescent imaging of Trypanosoma cruzi infection. Int J Parasitol. 2008, 38 (12): 1391-1400. 10.1016/j.ijpara.2008.04.002.PubMed CentralView ArticlePubMedGoogle Scholar
- Vazquez MP, Levin MJ: Functional analysis of the intergenic region of TcP2β gene loci allowed the construction of a improved Trypanosoma cruzi expression vector. Gene. 1999, 239: 217-225. 10.1016/S0378-1119(99)00386-8.View ArticlePubMedGoogle Scholar
- Cruz A, Beverley SM: Gene replacement in parasitic protozoa. Nature. 1990, 348: 171-173. 10.1038/348171a0.View ArticlePubMedGoogle Scholar
- Lorenzi HA, Vazquez MP, Levin MJ: Integration of expression vectors into the ribosomal locus of Trypanosoma cruzi. Gene. 2003, 310: 91-99.View ArticlePubMedGoogle Scholar
- Camargo EP: Growth and differentiation in Trypanosoma cruzi. Rev Inst Med São Paulo. 1964, 6: 93-100.Google Scholar
- Contreras VT, Salles JM, Thomas N, Morel CM, Goldenberg S: In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol. 1985, 16: 315-327. 10.1016/0166-6851(85)90073-8.View ArticlePubMedGoogle Scholar
- Close DM, Xu T, Sayler GS, Ripp S: In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals. Sensors. 2011, 11: 180-206.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee KH, Byun SS, Paik JY, Lee SY, Song SH, Choe YS, Kim BT: Cell uptake and tissue distribution of radioiodine labelled D-D-luciferin: Implications for luciferase based gene imaging. Nucl Med Commun. 2003, 24: 1003-1009. 10.1097/00006231-200309000-00009.View ArticlePubMedGoogle Scholar
- Keyaerts M, Verschueren J, Bos TJ, Tchouate-Gainkam LO, Peleman C, Breckpot K, Vanhove C, Caveliers V, Bossuyt A, Lahoutte T: Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-D-luciferin: Effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging. 2008, 35: 999-1007. 10.1007/s00259-007-0664-2.View ArticlePubMedGoogle Scholar
- Inoue Y, Kiryu S, Izawa K, Watanabe M, Tojo A, Ohtomo K: Comparison of subcutaneous and intraperitoneal injection of D-D-luciferin for in vivo bioluminescence imaging. Eur J Nucl Med Mol Imaging. 2009, 36: 771-779. 10.1007/s00259-008-1022-8.View ArticlePubMedGoogle Scholar
- Guevara P, Dias M, Rojas A, Crisante G, Abreu-Blanco MT, Umezawa E, Vazquez M, Levin M, Añez N, Ramirez JL: Expression of fluorescent genes in Trypanosoma cruzi and Trypanosoma rangeli (Kinetoplastida: Trypanosomatidae): its application to parasite-vector biology. J Med Entomol. 2005, 42 (1): 48-56. 10.1603/0022-2585(2005)042[0048:EOFGIT]2.0.CO;2.View ArticlePubMedGoogle Scholar
- Adjalley SH, Johnston GL, Li T, Eastman RT, Ekland EH, Eappen AG, Richman A, Sim BK, Lee MC, Hoffman SL, Fidock DA: Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci USA. 2011, 108 (47): E1214-E1223. 10.1073/pnas.1112037108.PubMed CentralView ArticlePubMedGoogle Scholar
- O’Donnell MJ: Too much of a good thing: how insects cope with excess ions or toxins in the diet. J Exp Biol. 2009, 212 (3): 363-372. 10.1242/jeb.023739.View ArticlePubMedGoogle Scholar
- Toh SQ, Glanfield A, Gobert GN, Jones KM: Heme and blood-feeding parasites: friends or foes?. Parasit Vectors. 2010, 3: 108-10.1186/1756-3305-3-108.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang Y, Bressler JP, Neal J, Lal B, Bhang HC, Laterra J, Pomper MG: ABCG2/BCRP Expression Modulates D-Luciferin–Based Bioluminescence Imaging. Cancer Res. 2007, 67: 9389-9397. 10.1158/0008-5472.CAN-07-0944.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.